血小板参数和乙氨基酸与疾病严重程度,CRP和稳定性COPD治疗之间的关系
Zeynep Mine Yalcinkaya Kara1, Sema Yagci1, Mufide Arzu Ozkarafakili2
1Department of Clinical Biochemistry, University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.
Sisli Etfal Hastanesi tip bulteni
|July 18, 2024
概括
慢性阻塞性肺病 (COPD) 患者的血小板与淋巴细胞比率 (PLR) 较高,这表明它可能表明正在进行的炎症. 需要进一步的研究,以探索血小板和乙素在COPD中的作用.
科学领域:
- 肺部医学 肺部医学
- 血液学 血液学 血液学
- 炎症研究 炎症研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种复杂的炎症状况,影响呼吸和潜在的血静.
- 除了C-反应蛋白之外,了解炎症标志物对于治疗COPD至关重要.
研究的目的:
- 为了研究COPD患者和健康对照者之间与血小板相关的参数和乙素的差异.
- 评估血小板指数作为稳定的COPD炎症生物标志物的潜力.
主要方法:
- 将149名稳定的COPD患者与30名健康对照进行比较.
- 测量了全血细胞计数,C反应蛋白和各种血小板参数,包括血小板计数 (Plt),平均血小板体积 (MPV),血小板分布宽度 (PDW),血小板克里特 (Pct) 和血小板与淋巴细胞比率 (PLR).
主要成果:
- 在大多数血小板参数 (Plt,Pct,PDW,MPV) 中,在COPD患者和对照组之间没有发现显著差异.
- 血小板与淋巴细胞的比率 (PLR) 在COPD患者中显著更高 (p=0.009).
- 血小板计数和PLR之间的相关性观察到边界显著性 (p=0.047;p=0.05).
结论:
- 血小板与淋巴细胞的比率 (PLR) 在稳定的COPD患者中升高.
- PLR可以作为评估COPD炎症的有价值和可访问的标志物.
- 建议进行进一步的大规模研究,以阐明血小板和乙素参数在COPD中的作用.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
01:26COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K